Literature DB >> 27476668

Subsequent Response of VWF and ADAMTS13 to Aortic Valve Replacement.

Koichi Kokame1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27476668      PMCID： PMC5098912          DOI： 10.5551/jat.ED055

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN： 1340-3478            Impact factor:   4.928


× No keyword cloud information.
  13 in total

1.  Early diagnosis of acquired von Willebrand Syndrome (AVWS) is elementary for clinical practice in patients treated with ECMO therapy.

Authors:  Johannes Kalbhenn; Rene Schmidt; Lea Nakamura; Johannes Schelling; Simone Rosenfelder; Barbara Zieger
Journal:  J Atheroscler Thromb       Date:  2014-09-04       Impact factor: 4.928

2.  von Willebrand factor abnormalities in aortic valve stenosis: Pathophysiology and impact on bleeding.

Authors:  Alessandra Casonato; Sandro Sponga; Elena Pontara; Maria Grazia Cattini; Cristina Basso; Gaetano Thiene; Giuseppe Cella; Viviana Daidone; Gino Gerosa; Antonio Pagnan
Journal:  Thromb Haemost       Date:  2011-05-05       Impact factor: 5.249

Review 3.  Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan.

Authors:  Y Fujimura; M Matsumoto; A Isonishi; H Yagi; K Kokame; K Soejima; M Murata; T Miyata
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

4.  von Willebrand factor multimerization and the polarity of secretory pathways in endothelial cells.

Authors:  Mafalda Lopes da Silva; Daniel F Cutler
Journal:  Blood       Date:  2016-04-22       Impact factor: 22.113

5.  Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor.

Authors:  Xiaohui Zhang; Kenneth Halvorsen; Cheng-Zhong Zhang; Wesley P Wong; Timothy A Springer
Journal:  Science       Date:  2009-06-05       Impact factor: 47.728

Review 6.  Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.

Authors:  J Evan Sadler
Journal:  Blood       Date:  2008-07-01       Impact factor: 22.113

Review 7.  Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura.

Authors:  U Budde; R Schneppenheim
Journal:  Hamostaseologie       Date:  2014-07-10       Impact factor: 1.778

8.  A novel ELISA-based diagnosis of acquired von Willebrand disease with increased VWF proteolysis.

Authors:  Antoine Rauch; Claudine Caron; Flavien Vincent; Emmanuelle Jeanpierre; Catherine Ternisien; Pierre Boisseau; Christophe Zawadzki; Edith Fressinaud; Annie Borel-Derlon; Sylvie Hermoire; Camille Paris; Cécile Lavenu-Bombled; Agnès Veyradier; Alexandre Ung; André Vincentelli; Eric van Belle; Peter J Lenting; Jenny Goudemand; Sophie Susen
Journal:  Thromb Haemost       Date:  2016-01-21       Impact factor: 5.249

Review 9.  Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update.

Authors:  Augusto B Federici; Ulrich Budde; Giancarlo Castaman; Jacob H Rand; Andreas Tiede
Journal:  Semin Thromb Hemost       Date:  2013-02-08       Impact factor: 4.180

Review 10.  Acquired von Willebrand syndrome associated with left ventricular assist device.

Authors:  Angelo Nascimbene; Sriram Neelamegham; O H Frazier; Joel L Moake; Jing-Fei Dong
Journal:  Blood       Date:  2016-05-03       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.